Jasminka Taleska MD,MBA

With over two decades of experience in the pharmaceutical industry, Dr. Jasminka Taleska has emerged as a strategic leader in healthcare system (HCS) readiness and shaping health policies. Her expertise in radioligand therapy has significantly increased global patient access and improved health outcomes. She is passionate about creating meaningful change in HCS and looks forward to new opportunities to drive innovation through policy and partnerships to transform patients’ lives worldwide.